APBB2
Basic information
Region (hg38): 4:40810027-41216714
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APBB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 44 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 0 | 0 |
Variants in APBB2
This is a list of pathogenic ClinVar variants found in the APBB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-40816141-G-A | not specified | Uncertain significance (Jun 05, 2023) | ||
4-40816192-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
4-40816195-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
4-40816199-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
4-40816205-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
4-40821893-T-A | not specified | Uncertain significance (Jan 12, 2024) | ||
4-40823649-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
4-40823714-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
4-40825926-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
4-40827150-G-C | not specified | Uncertain significance (Nov 03, 2023) | ||
4-40827165-T-C | not specified | Uncertain significance (Jun 17, 2022) | ||
4-40830468-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
4-40890394-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
4-40890404-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
4-40893294-T-G | not specified | Uncertain significance (Jul 16, 2021) | ||
4-40893354-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
4-40893360-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
4-40893369-C-T | not specified | Uncertain significance (Nov 30, 2021) | ||
4-40934663-A-T | not specified | Uncertain significance (Oct 12, 2021) | ||
4-40944918-A-G | not specified | Uncertain significance (Mar 22, 2022) | ||
4-40944921-C-G | not specified | Uncertain significance (Dec 28, 2022) | ||
4-40944945-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
4-40944975-G-C | not specified | Uncertain significance (Sep 15, 2021) | ||
4-40945005-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
4-40945073-G-A | not specified | Uncertain significance (Dec 05, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APBB2 | protein_coding | protein_coding | ENST00000508593 | 14 | 406688 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0652 | 0.935 | 124772 | 0 | 29 | 124801 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.12 | 320 | 446 | 0.717 | 0.0000262 | 5000 |
Missense in Polyphen | 119 | 203.05 | 0.58607 | 2207 | ||
Synonymous | 0.187 | 176 | 179 | 0.982 | 0.0000118 | 1487 |
Loss of Function | 4.26 | 10 | 38.5 | 0.260 | 0.00000229 | 406 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000220 | 0.000220 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.000150 | 0.000150 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: May modulate the internalization of amyloid-beta precursor protein.;
Recessive Scores
- pRec
- 0.237
Intolerance Scores
- loftool
- 0.741
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.16
Haploinsufficiency Scores
- pHI
- 0.408
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.921
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Apbb2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- neuron migration;regulation of transcription, DNA-templated;cell cycle arrest;axon guidance;extracellular matrix organization;negative regulation of cell growth;intracellular signal transduction;positive regulation of apoptotic process;negative regulation of apoptotic process
- Cellular component
- nucleus;cytoplasm;membrane;lamellipodium;growth cone;synapse
- Molecular function
- amyloid-beta binding;protein binding;transcription factor binding